Welcome to the Institute for Diabetes, Obesity and Metabolism
and Penn Diabetes Research Center
The IDOM was established in 2005 to address the ever increasing prevalence of diabetes and obesity. In 2016, there were 29.1 million people with diabetes in the United States, and more than one-third of U.S. adults are obese. In 2012, the cost of diabetes was estimated at $245 billion per year, and the Centers for Disease Control has projected that one out of three children born in the year 2000 will develop diabetes in his or her lifetime.
The mission of the IDOM is to support and develop successful approaches to the prevention, treatment, and cure of diabetes mellitus and obesity.Learn more about IDOM and DRC >>
Insulin Signaling Molecule in Liver Controls Levels of Triglyceride in Blood.
Penn Medicine study has implications for metabolic disease, insulin resistance, diabetes, and cardiovascular disease. Researchers from the Perelman School of Medicine at the University of Pennsylvania published their findings in the Journal of Clinical Investigation (JCI).
Read more: Penn Medicine Press Release
Dr. Agarwal advocates for diabetes care
Shivani Agarwal, MD, MPH pictured with Senator Cory Booker, went to Washington, D.C. to advocate for diabetes care.
Seminars & Events
November 28, 2017
Jared P. Rutter., Ph.D., – University of Utah.
Title: “Mitochondria, Metabolism and Cellular Decision: Entwined in Health and Disease”
December 5, 2017
David A. D'Alessio, M.D., – Duke University.
Title: "Is GLP-1 a Hormone: Whether and When?"
December 12, 2017
Carey Lumeng, M.D., Ph.D. – University of Michigan.
Title: "Adipose Tissue Leukocyte Activation and Metabolic Disease"
December 19, 2017
Gary D. Wu, M.D., – University of Pennsylvania.
Title: "Of Mice and Men in the Dietary Manipulation of the Gut Microbiome: The Importance of Human Research"